Peanut Oral Immunotherapy Using 30 and 300 mg Maintenance Doses
A 30 mg maintenance dose for P-OIT significantly increases the threshold over strict avoidance, clinically similarly to 300 mg, and may allow for a simplified and safer immunotherapy regimen and fewer treatment dropouts.
Authors
- Diana Toscano Rivero
- Liane Beaudette
- Duncan Lejtenyi
- Thomas Eiwegger (ORCID: https://orcid.org/0000-0002-2914-7829)
- Bruce Mazer (ORCID: https://orcid.org/0000-0003-4018-1419)
- Lucy Duan (ORCID: https://orcid.org/0000-0002-0560-583X)
- Danbing Ke (ORCID: https://orcid.org/0009-0000-6483-7895)
- Julia Upton (ORCID: https://orcid.org/0000-0001-5320-4232)
- Vy Kim
- Alireza Berenjy (ORCID: https://orcid.org/0000-0003-0003-9266)
- Moshe Ben‐Shoshan (ORCID: https://orcid.org/0000-0001-9083-1518)
- Eyal Grunebaum (ORCID: https://orcid.org/0000-0002-2586-6391)
- Xiaojun Yin (ORCID: https://orcid.org/0000-0002-5925-297X)
- Carmen Li (ORCID: https://orcid.org/0000-0002-6135-2582)
- Casey Cohen
- Christine McCusker (ORCID: https://orcid.org/0000-0003-2150-9159)
- Shireen Marzouk
Institutions
- Montreal Children's Hospital (CA)
- Hospital for Sick Children (CA)
- McGill University Health Centre (CA)
- Universitätsklinikum St. Pölten (AT)
- SickKids Foundation (CA)
- Imperial College London (GB)
Publication Details
- Journal
- The Journal of Allergy and Clinical Immunology In Practice
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1016/j.jaip.2025.10.007
- Citations
- 2
- Primary Topic
- Peanut Plant Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.50